About 59% of small molecule drugs approved by the Food and Drug Administration (FDA) contain at least one nitrogen-based heterocycle, where newly approved derivatives involve as much as 82% N-heterocycles. (1,2) Among these active pharmaceutical ingredients (APIs), benzimidazole moieties are common structural motifs that lead to a variety of therapeutic applications.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Aaron
Contact Aaron, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack